作者对重组乙型肝炎疫苗与血源疫苗的免疫原性作了比较.试验对象为55名男性新兵,年龄17～19岁.所有受试者都对乙型肝炎病毒易感.接种方法为,每人每次肌肉接种10μg重组疫苗(Merck药厂生产,批号979/C-K564),共接种3次,分别于0、1和6月 The authors compared the immunogenicity of recombinant hepatitis B vaccine against that of a blood-borne vaccine, and 55 subjects were recruited, aged 17-19 years, all of whom were susceptible to hepatitis B. Inoculation methods were as follows: 10 μg recombinant vaccine (Merck Pharmaceutical Factory, Lot 979 / C-K564) was inoculated intramuscularly for 3 times each at 0, 1 and 6 months